Issue of Equity
Updated : 16:54
13 December 2024
FD Technologies plc
Issue of Equity
FD Technologies plc (the "Company") (AIM: FDP.L, Euronext Growth: FDP.I) announces that on 13 December 2024 the Company allotted 12,000 new ordinary shares of £0.005 each in the Company ("the Ordinary Shares"). The allotment is pursuant to the exercise of share options by certain employees.
Application has been made for the new Ordinary Shares to be admitted to trading on AIM and Euronext Growth and it is expected that admission will take place on 19 December 2024. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 28,231,641 ordinary shares.
Enquiries
For further information please contact:
FD Technologies plc Derek Brown, Head of Investor Relations | +44(0)28 3025 2242 | |
| ||
Investec Bank plc (Nominated Adviser and Broker) Carlton Nelson Virginia Bull | +44 (0) 20 7597 5970 | |
FTI Consulting LLP (Financial PR) Matt Dixon Dwight Burden Victoria Caton | +44 (0) 20 3727 1000 FDtechnologies@fticonsulting.com |
|
About KX
KX is on a mission to make AI a commercial reality for the many by addressing data challenges that impede deployment at scale. By simultaneously ingesting and analysing high volumes of historical and real-time data, KX's AI-ready analytical database enables organizations to unlock the full value of their data to accelerate innovation and make faster, more confident decisions.
KX is the world's most performant, cost-effective and energy-efficient analytical database, delivering advanced data algorithms, insights and analytics at unmatched scale and speed. KX is trusted by the world's top investment banks, Aerospace and Defence, high-tech manufacturing and health and life sciences organizations and operates across North America, Europe, and Asia Pacific.
For further information, please visit www.fdtechnologies.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.